CLINICAL_TRIALS
research
· 2025-07-11
Clinical Trial Update: Gastrin, Anti-helicobacter Pylori and Pepsinogen Diagnostic Accuracy Study
Summary
A diagnostic accuracy study evaluating gastrin, Helicobacter pylori status, and pepsinogen as markers for gastric atrophy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Royal College of Surgeons, Ireland | Conditions: Gastric Atrophy | Status: NOT_YET_RECRUITING